Skip to main content
Top
Published in: Annals of Surgical Oncology 2/2015

01-02-2015 | Breast Oncology

Initial Results with Preoperative Tattooing of Biopsied Axillary Lymph Nodes and Correlation to Sentinel Lymph Nodes in Breast Cancer Patients

Authors: Nicole Choy, MD, Jafi Lipson, MD, Catherine Porter, DO, Michael Ozawa, MD, Anne Kieryn, MD, Sunita Pal, MD, Jennifer Kao, MD, Long Trinh, MD, Amanda Wheeler, MD, FACS, Debra Ikeda, MD, FACR, Kristin Jensen, MD, Kimberly Allison, MD, Irene Wapnir, MD, FACS

Published in: Annals of Surgical Oncology | Issue 2/2015

Login to get access

Abstract

Background

Pretreatment evaluation of axillary lymph nodes (ALNs) and marking of biopsied nodes in patients with newly diagnosed breast cancer is becoming routine practice. We sought to test tattooing of biopsied ALNs with a sterile black carbon suspension (Spot™). The intraoperative success of identifying tattooed ALNs and their concordance to sentinel nodes was determined.

Methods

Women with suspicious ALNs and newly diagnosed breast cancer underwent palpation and/or ultrasound-guided fine needle aspiration or core needle biopsy, followed by injection of 0.1 to 0.5 ml of Spot™ ink into the cortex of ALNs and adjacent soft tissue. Group I underwent surgery first, and group II underwent neoadjuvant therapy followed by surgery. Identification of black pigment and concordance between sentinel and tattooed nodes was evaluated.

Results

Twenty-eight patients were tattooed, 16 in group I and 12 in group II. Seventeen cases had evidence of atypia or metastases, 8 (50 %) in group I and 9 (75 %) in group II. Average number of days from tattooing to surgery was 22.9 (group I) and 130 (group II). Black tattoo ink was visualized intraoperatively in all cases, except one case with microscopic black pigment only. Fourteen group I and 10 group II patients had black pigment on histological examination of ALNs. Sentinel nodes corresponded to tattooed nodes in all except one group I patient with a tattooed non-sentinel node.

Conclusion

Tattooed nodes are visible intraoperatively, even months later. This approach obviates the need for additional localization procedures during axillary staging.
Literature
1.
go back to reference Boughey JC, Suman VJ, Mittendorf EA, et. al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer. The ACOSOG Z1071 (Alliance) Clinical Trial. JAMA. 2013;310:1455–61.PubMedCentralPubMedCrossRef Boughey JC, Suman VJ, Mittendorf EA, et. al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer. The ACOSOG Z1071 (Alliance) Clinical Trial. JAMA. 2013;310:1455–61.PubMedCentralPubMedCrossRef
2.
go back to reference Caudle AS, Cupp JA, Kuerer HM. Management of axillary disease. Surg Oncol Clin N Am. 2014;23:473–86.PubMedCrossRef Caudle AS, Cupp JA, Kuerer HM. Management of axillary disease. Surg Oncol Clin N Am. 2014;23:473–86.PubMedCrossRef
3.
go back to reference Morrow M, Dang CT. Sentinel node biopsy after neoadjuvant chemotherapy, a new standard for patients with axillary metastases? JAMA. 2013;310(14):1449–50.PubMedCrossRef Morrow M, Dang CT. Sentinel node biopsy after neoadjuvant chemotherapy, a new standard for patients with axillary metastases? JAMA. 2013;310(14):1449–50.PubMedCrossRef
4.
go back to reference Bryant JA, Siddiqi NJ, Loveday EJ, Irvine GH. Presurgical, ultrasound-guided anchor-wire marking of impalpable cervical lymph nodes. J Laryngol Otol. 2005;119(8):627–8.PubMedCrossRef Bryant JA, Siddiqi NJ, Loveday EJ, Irvine GH. Presurgical, ultrasound-guided anchor-wire marking of impalpable cervical lymph nodes. J Laryngol Otol. 2005;119(8):627–8.PubMedCrossRef
5.
go back to reference Straver ME, Loo CE. Alderliesten T, Rutgers EJT, Vrancken Peeters MTFD. Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer. Br J Surg. 2010;97:1226–31.PubMedCrossRef Straver ME, Loo CE. Alderliesten T, Rutgers EJT, Vrancken Peeters MTFD. Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer. Br J Surg. 2010;97:1226–31.PubMedCrossRef
6.
go back to reference Donker MD, Straver ME, Wesseling J, Loo CE, Schot M, Drukker CA, et al. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Ann Surg. Epub 16 Apr 2014. Donker MD, Straver ME, Wesseling J, Loo CE, Schot M, Drukker CA, et al. Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. Ann Surg. Epub 16 Apr 2014.
7.
go back to reference Shatz BA, Weinstock LB, Swanson PE, Thyssen EP. Long-term safety of India ink tattoos in the colon. Gastrointest Endosc. 1997;45:153–6.PubMedCrossRef Shatz BA, Weinstock LB, Swanson PE, Thyssen EP. Long-term safety of India ink tattoos in the colon. Gastrointest Endosc. 1997;45:153–6.PubMedCrossRef
8.
go back to reference Askin MP, Waye JD, Fiedler L, Harpaz N. Tattoo of colonic neoplasms in 113 patients with a new sterile carbon compound. Gastrointest Endosc. 2002;56:339–42.PubMedCrossRef Askin MP, Waye JD, Fiedler L, Harpaz N. Tattoo of colonic neoplasms in 113 patients with a new sterile carbon compound. Gastrointest Endosc. 2002;56:339–42.PubMedCrossRef
9.
go back to reference Mainiero MB. Regional lymph node staging in breast cancer: the increasing role of imaging and ultrasound-guided axillary lymph node fine needle aspiration. Radiol Clin N Am. 2010;48:989–97.PubMedCrossRef Mainiero MB. Regional lymph node staging in breast cancer: the increasing role of imaging and ultrasound-guided axillary lymph node fine needle aspiration. Radiol Clin N Am. 2010;48:989–97.PubMedCrossRef
10.
go back to reference Yamashita M, Hovanessian-Larsen L, Sener SF. The role of axillary ultrasound in the detection of metastases from primary breast cancers. Am J Surg. 2013;205:242–4.PubMedCrossRef Yamashita M, Hovanessian-Larsen L, Sener SF. The role of axillary ultrasound in the detection of metastases from primary breast cancers. Am J Surg. 2013;205:242–4.PubMedCrossRef
11.
go back to reference Lee, B, Lim AK, Krell J, Satchithananda K, Coombes RC, Lewis JS, et al. The efficacy of axillary ultrasound in the detection of nodal metastasis in breast cancer. J Am J Roentgenol. 2013;200:W314–20.CrossRef Lee, B, Lim AK, Krell J, Satchithananda K, Coombes RC, Lewis JS, et al. The efficacy of axillary ultrasound in the detection of nodal metastasis in breast cancer. J Am J Roentgenol. 2013;200:W314–20.CrossRef
12.
go back to reference Rautiainen S, Masarwah A, Sudah M, Sutela A, Pelkonen O, Joukainen S, et al. Axillary lymph node biopsy in newly diagnosed invasive breast cancer: comparative accuracy of fine-needle aspiration biopsy versus core-needle biopsy. Radiology. 2013;269:54–60.PubMedCrossRef Rautiainen S, Masarwah A, Sudah M, Sutela A, Pelkonen O, Joukainen S, et al. Axillary lymph node biopsy in newly diagnosed invasive breast cancer: comparative accuracy of fine-needle aspiration biopsy versus core-needle biopsy. Radiology. 2013;269:54–60.PubMedCrossRef
13.
go back to reference van Rijk MC, Nieweg OE, Rutgers EJ, Oldenburg HS, Olmos RV, Hoefnagel CA, et al. Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection. Ann Surg Oncol. 2006;13:475–9.PubMedCrossRef van Rijk MC, Nieweg OE, Rutgers EJ, Oldenburg HS, Olmos RV, Hoefnagel CA, et al. Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection. Ann Surg Oncol. 2006;13:475–9.PubMedCrossRef
14.
go back to reference Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer: a multicenter validation Study. N Engl J Med. 1998;339(14):941–6.PubMedCrossRef Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer: a multicenter validation Study. N Engl J Med. 1998;339(14):941–6.PubMedCrossRef
15.
go back to reference Alvarez S, Añorbe E, Alcorta P, López F, Alonso I, Cortés J. Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. Am J Roentgenol. 2006;186:1342–8.CrossRef Alvarez S, Añorbe E, Alcorta P, López F, Alonso I, Cortés J. Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. Am J Roentgenol. 2006;186:1342–8.CrossRef
16.
go back to reference Ibrahim-Zada I, Grant CS, Glazebrook KN, Boughey JC. Preoperative axillary ultrasound in breast cancer: safely avoiding frozen section of sentinel lymph nodes in breast-conserving surgery. J Am Coll Surg. 2013;217:7–15.PubMedCentralPubMedCrossRef Ibrahim-Zada I, Grant CS, Glazebrook KN, Boughey JC. Preoperative axillary ultrasound in breast cancer: safely avoiding frozen section of sentinel lymph nodes in breast-conserving surgery. J Am Coll Surg. 2013;217:7–15.PubMedCentralPubMedCrossRef
17.
go back to reference Holwitt DM, Swatske ME, Gillanders WE, Monsees BS, Gao F, Aft RL, et al. The combination of axillary ultrasound and ultrasound-guided biopsy in an accurate predictor of axillary stage in clinically node-negative breast cancer patients. Am J Surg. 2008;196:477–82.PubMedCentralPubMedCrossRef Holwitt DM, Swatske ME, Gillanders WE, Monsees BS, Gao F, Aft RL, et al. The combination of axillary ultrasound and ultrasound-guided biopsy in an accurate predictor of axillary stage in clinically node-negative breast cancer patients. Am J Surg. 2008;196:477–82.PubMedCentralPubMedCrossRef
18.
go back to reference Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis. JAMA. 2011;305(6):569–75.PubMedCrossRef Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis. JAMA. 2011;305(6):569–75.PubMedCrossRef
19.
go back to reference Rouzier R, Extra JM, Klijanienko J, et. al. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. J Clin Oncol. 2002;20:1304–10.PubMedCrossRef Rouzier R, Extra JM, Klijanienko J, et. al. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes. J Clin Oncol. 2002;20:1304–10.PubMedCrossRef
20.
go back to reference Kuerer HM, Sahin AA, Hunt KK, Newman LA, Breslin TM, Ames FC, et al. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg. 1999;230:72–8.PubMedCentralPubMedCrossRef Kuerer HM, Sahin AA, Hunt KK, Newman LA, Breslin TM, Ames FC, et al. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg. 1999;230:72–8.PubMedCentralPubMedCrossRef
21.
go back to reference Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014;384(9938):164–72.PubMedCrossRef Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014;384(9938):164–72.PubMedCrossRef
22.
go back to reference Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14:609–18.PubMedCrossRef Kuehn T, Bauerfeind I, Fehm T, Fleige B, Hausschild M, Helms G, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14:609–18.PubMedCrossRef
23.
go back to reference Boughey JC, Suman VJ, Mittendorf EA, et al. The role of sentinel lymph node surgery in patients with node positive breast cancer (T0–T4, N1-2) who receive neoadjuvant chemotherapy: results from the ACOSOG Z1017 trial [abstract no. S2-1]. Presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium; 4–8 Dec 2012; San Antonio. Boughey JC, Suman VJ, Mittendorf EA, et al. The role of sentinel lymph node surgery in patients with node positive breast cancer (T0–T4, N1-2) who receive neoadjuvant chemotherapy: results from the ACOSOG Z1017 trial [abstract no. S2-1]. Presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium; 4–8 Dec 2012; San Antonio.
24.
go back to reference Gradishar W, Anderson BO, Blair S et al. Breast cancer version 3.2014. J Natl Compr Netw. 2014;12:542–90. Gradishar W, Anderson BO, Blair S et al. Breast cancer version 3.2014. J Natl Compr Netw. 2014;12:542–90.
Metadata
Title
Initial Results with Preoperative Tattooing of Biopsied Axillary Lymph Nodes and Correlation to Sentinel Lymph Nodes in Breast Cancer Patients
Authors
Nicole Choy, MD
Jafi Lipson, MD
Catherine Porter, DO
Michael Ozawa, MD
Anne Kieryn, MD
Sunita Pal, MD
Jennifer Kao, MD
Long Trinh, MD
Amanda Wheeler, MD, FACS
Debra Ikeda, MD, FACR
Kristin Jensen, MD
Kimberly Allison, MD
Irene Wapnir, MD, FACS
Publication date
01-02-2015
Publisher
Springer US
Published in
Annals of Surgical Oncology / Issue 2/2015
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-4034-6

Other articles of this Issue 2/2015

Annals of Surgical Oncology 2/2015 Go to the issue